SymbioCellTech
PrivateLast Round
Seed
Jun 24, 2016
Total Funding Raised
$7.5M
Company Overview
SymbioCellTech operates in Healthcare & Life Sciences and is based in Salt Lake City, Utah. Its latest recorded funding round was a Seed round in June 2016.
SymbioCellTech is a biotechnology company that develops stem cell-enabled therapies for the treatment of type 1 diabetes and other autoimmune and degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SymbioCellTech Comparables
Compare SymbioCellTech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seraxis | 88% | |
| CellTrans Inc. | 83% | |
| ALTuCELL | 79% |
For institutional investors. Book with your work email.
SymbioCellTech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 24, 2016 | ||||
| Seed | Aug 15, 2014 | ||||
| Seed | Mar 20, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors grew 37% MoM, reaching 973.
- Jun 24, 2016
$1.9M raised in Seed round
For institutional investors. Book with your work email.
SymbioCellTech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SymbioCellTech's valuation, stock price, and market status.
Is SymbioCellTech a public or private company?
SymbioCellTech is a private company.
What is the current stock price of SymbioCellTech?
SymbioCellTech is a private company, so its shares have no public market price. Caplight tracks SymbioCellTech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SymbioCellTech worth (valuation)?
Valuation information for SymbioCellTech is not publicly available.
Can I buy SymbioCellTech stock?
SymbioCellTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SymbioCellTech's last funding round?
SymbioCellTech's most recent funding round was Seed on June 24, 2016.
Who are the main investors in SymbioCellTech?
Investor information for SymbioCellTech is not publicly disclosed.
Will SymbioCellTech IPO soon?
No public IPO plans have been announced for SymbioCellTech.
How can I track SymbioCellTech secondary market activity?
Caplight tracks bids, offers, and trades in SymbioCellTech's shares on secondary markets.